2007-2008 Grant Cycle : Research Grants Awarded
Diagnostic & Prognostic Biomarkers
Prospective Evaluation Of Molecular Triaging With Pharmacogenomic Tests To Select Neoadjuvant Treatment
William Symmans*, M.D.
Lajos Pusztai, MD, PhD
M.D. Anderson Cancer Center, University of Texas
Promise Grant
$998,688
Salivary Diagnostics To Identify And Diagnose Breast Cancer
Charles Streckfus*, DDS
University of Texas at Health Science Center at Houston
Investigator Initiated Research
$429,634
Array-Based Gene Methylation Profiling For The Characterization Of Breast Tumors In African-American And White Women
Kathleen Dorsey, Ph.D.
University of North Carolina at Chapel Hill
Investigator Initiated Research
$599,997
A Comparison Of Diagnostic Performance Of Digital Breast Tomosynthesis (Dbt), Cone Beam Ct (Cbct) And Mri In Women With Known Breast Abnormalities
Margarita Zuley, M.D.
University of Pittsburgh
Investigator Initiated Research
$588,018
Early Detection And Prediction Of Chemotherapy-Induced Cardiotoxicity In Breast Cancer Patients.
Marielle Scherrer-Crosbie, M.D., Ph.D.
Massachusetts General Hospital
Investigator Initiated Research
$600,000
Development Of A Methylation Panel To Determine Breast Cancer Recurrence Risk: Using The Breast Cancer Hypermethylome To Identify Highly Promising Biomarkers
Nita Ahuja, M.D.
Johns Hopkins University, Kimmel Cancer Center
Investigator Initiated Research
$573,030
Integrating Computational And Experimental Biology To Discover Novel Biomarkers: Activating Mutations In The Breast Cancer Oncogene Pik3Ca
Rachel Karchin, Ph.D.
Johns Hopkins University
Investigator Initiated Research
$599,798
Accurate, Reproducible And Automated Breast Histopathology Without The Use Of Stains Or Human Input
Rohit Bhargava, Ph.D.
University of Illinois at Champaign and Urbana
Investigator Initiated Research
$600,000
Identification And Treatment-Monitoring Using Advanced Ultrasonic Imaging Methods
Sheikh Alam, Ph.D.
Riverside Research Institute
Investigator Initiated Research
$594,000
Biomarker Analysis In Ductal Carcinoma In Situ Of The Breast
Agnieszka Witkiewicz, M.D.
Thomas Jefferson University
Career Catalyst Research
$450,000
Caper: A Novel Biomarker For Predicting Ductal Carcinoma In Situ (Dcis) Progression To Invasive Breast Cancer ?
Jean-Francois Jasmin, Ph.D.
Thomas Jefferson University
Career Catalyst Research
$450,001
Imaging Metastatic Potentials Of Breast Cancer
Lin Li, Ph.D.
University of Pennsylvania School of Medicine
Career Catalyst Research
$448,837
Mammary Stem Cells And Proteomic Biomarkers Of Benign Breast Disease: Molecular Tools To Improve Breast Cancer Risk Prediction.
Andrew Godwin, Ph.D.
Dana A Pape-Zambito, PhD
Fox Chase Cancer Center
Postdoctoral Fellowships
$180,000
Tomosynthesis Texture Biomarkers For Computer-Assisted Risk Estimation (Care) Of Breast Cancer
Andrew Maidment, Ph.D.
Despina Kontos, PhD
University of Pennsylvania School of Medicine
Postdoctoral Fellowships
$120,000
Cyclin E Mediates Response To Chemotherapeutic Agents In Breast Cancer
Kelly Hunt, Ph.D.
Hannah Wingate, PhD
M.D. Anderson Cancer Center, University of Texas
Postdoctoral Fellowships
$180,000
Overcoming Primary Herceptin Resistance In Breast Cancer
Nita Maihle, Ph.D.
Jason A Wilken, PhD
Yale University
Postdoctoral Fellowships
$180,000
Polycomb-Mediated Aberrant Dna Methylation As A Biomarker For Early Breast Cancer Detection
Peter Laird, Ph.D.
Romulo M Brena, PhD
University of Southern California
Postdoctoral Fellowships
$180,000
Multimodality-Enabled Optical Imaging Agents For Breast Cancers
Ya-Ping Sun, Ph.D.
Li Cao, PhD
Clemson University
Postdoctoral Fellowships
$180,000
Co-funded by Komen Upstate South Carolina Affiliat
* Pending executed agreement
